Bobby Gaspar, founder and CEO of Orchard Therapeutics, discusses the company’s sharpened focus, its gene therapy in development for metachromatic leukodystrophy, and where he sees the greatest opportunities for Orchard going forward

After Pruning Orchard, Gaspar Focuses on High Value Opportunities

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share After Pruning Orchard, Gaspar Focuses on High Value Opportunities

Sign up to save your podcasts

After Pruning Orchard, Gaspar Focuses on High Value Opportunities

After Pruning Orchard, Gaspar Focuses on High Value Opportunities